Publications
316
Citations
78,620
Est. group size
~1
Recurring co-author estimate
Active years
22
Publishing since 2005
Julie M. Gastier-Foster's research focuses on the genetics and molecular diagnostics of pediatric and young-adult cancers, especially leukemia, lymphoma, and neuroblastoma, often as part of large multi-institutional consortia like the Children's Oncology Group. Her work spans risk stratification using genomic and DNA methylation markers, disparities in cancer outcomes, and building cancer diagnostic capacity in resource-limited settings such as Malawi.
Publication output was higher and more variable earlier in the decade (peaking around 2018) and has generally declined in recent years, settling into a lower but still active pace.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Supplementary Figure S1 from Sequential Combination of Unfavorable Histology, Followed by Clinical Stage M, Defines High-Risk Neuroblastoma: A Report from the Children’s Oncology Group
2026
- Supplementary Table S1 from Sequential Combination of Unfavorable Histology, Followed by Clinical Stage M, Defines High-Risk Neuroblastoma: A Report from the Children’s Oncology Group
2026
- Supplementary Table S2 from Sequential Combination of Unfavorable Histology, Followed by Clinical Stage M, Defines High-Risk Neuroblastoma: A Report from the Children’s Oncology Group
2026
- Sequential Combination of Unfavorable Histology, Followed by Clinical Stage M, Defines High-Risk Neuroblastoma: A Report from the Children’s Oncology Group
Clinical Cancer Research · 2025
- DNA Methylation Epitypes of Burkitt Lymphoma with Distinct Molecular and Clinical Features
Blood Cancer Discovery · 2025
- Pediatric Malignant Tumors in Malawi: A Diagnostic Report From the Kamuzu Central Hospital Pathology Laboratory 2011–2020
Pediatric Blood & Cancer · 2025
- High-Dose Methotrexate Usage Without Drug-Level Monitoring in Advanced Pediatric Mature B-Cell Non-Hodgkin Lymphoma in a Resource-Limited Setting in Malawi
JCO Global Oncology · 2025
- Data from DNA Methylation Epitypes of Burkitt Lymphoma with Distinct Molecular and Clinical Features
2025
- Supplementary Tables from DNA Methylation Epitypes of Burkitt Lymphoma with Distinct Molecular and Clinical Features
2025
- Supplementary Figures from DNA Methylation Epitypes of Burkitt Lymphoma with Distinct Molecular and Clinical Features
2025
- Inferring chromosome segregation error stage and crossover in trisomic disorders with application to Down syndrome
Nature Communications · 2025
- 1. Rare oncogenic structural variations in FGFR genes in childhood brain tumors provide potential therapeutic targets
Cancer Genetics · 2025
- Enhanced Risk Stratification for Children and Young Adults with B-Cell Acute Lymphoblastic Leukemia: A Children’s Oncology Group Report
Leukemia · 2024
- Building capacity for pediatric hematological diseases in Sub-Saharan Africa
Blood Advances · 2024
- Update on pathology laboratory development and research in advancing regional cancer care in Malawi
Frontiers in Medicine · 2024
- Blood×21
- Journal of Clinical Oncology×20
- Cell Reports×11
- Cancer Cell×10
- Cell×8
- Susan I. Colace
Medicine · The Ohio State University
- Shalini C. Reshmi
Medicine · The Ohio State University
- Sandeep Batra
Medicine · Indiana University
- Rahul Nahar
Medicine · Purdue University West Lafayette
- A W Craft
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile